CFEA: a cell-free epigenome atlas in human diseases
Open Access
- 20 August 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 48 (D1) , D40-D44
Abstract
Epigenetic alterations, including 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC) and nucleosome positioning (NP), in cell-free DNA (cfDNA) have been widely observed in human diseases, and many available cfDNA-based epigenome-wide profiles exhibit high sensitivity and specificity in disease detection and classification. However, due to the lack of efficient collection, standardized quality control, and analysis procedures, efficiently integrating and reusing these data remain considerable challenges. Here, we introduce CFEA (http://www.bio-data.cn/CFEA), a cell-free epigenome database dedicated to three types of widely adopted epigenetic modifications (5mC, 5hmC and NP) involved in 27 human diseases. We developed bioinformatic pipelines for quality control and standard data processing and an easy-to-use web interface to facilitate the query, visualization and download of these cell-free epigenome data. We also manually curated related biological and clinical information for each profile, allowing users to better browse and compare cfDNA epigenomes at a specific stage (such as early- or metastasis-stage) of cancer development. CFEA provides a comprehensive and timely resource to the scientific community and supports the development of liquid biopsy-based biomarkers for various human diseases.Keywords
Funding Information
- National Natural Science Foundation of China (61871294, 61873193, 81822030)
- Science Foundation of Zhejiang Province (LR19C060001)
- Beijing Natural Science Foundation (7172175)
- Special Foundation for Key Basic Research of Wenzhou Institute of Biomaterials and Engineering (WIBEZD2017009-05)
- CAMS Innovation Fund for Medical Sciences (2016-I2M-1-001, 2017-I2M-3-004)
This publication has 25 references indexed in Scilit:
- Genome-wide cell-free DNA fragmentation in patients with cancerNature, 2019
- Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and diseaseNature Communications, 2018
- Sensitive tumour detection and classification using plasma cell-free DNA methylomesNature, 2018
- Current and future perspectives of liquid biopsies in genomics-driven oncologyNature Reviews Genetics, 2018
- Application of Cell-free DNA Analysis to Cancer TreatmentNew England Journal of Medicine, 2018
- Principles of DNA methylation and their implications for biology and medicineThe Lancet, 2018
- Clinical potential of circulating tumour DNA in patients receiving anticancer immunotherapyNature Reviews Clinical Oncology, 2018
- 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancersCell Research, 2017
- Inferring expressed genes by whole-genome sequencing of plasma DNANature Genetics, 2016
- Liquid Biopsies: Genotyping Circulating Tumor DNAJournal of Clinical Oncology, 2014